204 related articles for article (PubMed ID: 19487876)
21. Giant frontal colliding meningiomas in a child: histopathologic, cytogenetic, and ultrastructural descriptions of a unique case.
El Jamal SM; Raja A; Saad AG
Pediatr Dev Pathol; 2011; 14(4):333-8. PubMed ID: 21417911
[TBL] [Abstract][Full Text] [Related]
22. CNS Resident Award. Malignant meningiomas frequently lose multiple chromosomal regions in addition to 22q: putative meningioma progression loci identified by comparative genomic hybridization.
Metzger AK; Minn YA; Lieberman D; Bollen AW; Wilson CB; Feuerstein BG
Clin Neurosurg; 1999; 45():6-7. PubMed ID: 10461493
[No Abstract] [Full Text] [Related]
23. Gene expression profiles of meningiomas are associated with tumor cytogenetics and patient outcome.
Tabernero MD; Maillo A; Gil-Bellosta CJ; Castrillo A; Sousa P; Merino M; Orfao A
Brain Pathol; 2009 Jul; 19(3):409-20. PubMed ID: 18637901
[TBL] [Abstract][Full Text] [Related]
24. Pathology of meningiomas.
Langford LA
J Neurooncol; 1996 Sep; 29(3):217-21. PubMed ID: 8858527
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
Begnami MD; Rushing EJ; Santi M; Quezado M
Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763
[TBL] [Abstract][Full Text] [Related]
26. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis].
Cremerius U; Striepecke E; Henn W; Weis J; Mull M; Lippitz B; Gilsbach J; Schröder JM; Zang KD; Böcking A
Nuklearmedizin; 1994 Aug; 33(4):144-9. PubMed ID: 7971289
[TBL] [Abstract][Full Text] [Related]
27. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
Murnyák B; Csonka T; Hortobágyi T
Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
[TBL] [Abstract][Full Text] [Related]
28. [Chemosensitivity of cultured meningiomas].
Tsuchida T; Matsudaira T; Yoshimura K; Matsumoto M; Shirayama Y; Numa Y; Kawamoto K
Hum Cell; 1995 Dec; 8(4):155-6. PubMed ID: 8721084
[TBL] [Abstract][Full Text] [Related]
29. Pediatric meningosarcoma: clinical evolution and genetic instability.
de Mesa RL; Sierrasesúmaga L; de Cerain AL; Calasanz MJ; Patiño-García A
Pediatr Neurol; 2005 May; 32(5):352-4. PubMed ID: 15866438
[TBL] [Abstract][Full Text] [Related]
30. Comment concerning: Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas, Acta Neurochir DOl 1O.1007/s00701-010-0708-4, Intratumoral heterogeneity and fluorescence intensity in meningioma after 5-ALA pretreatment.
Hefti M
Acta Neurochir (Wien); 2011 Apr; 153(4):959-60. PubMed ID: 21279659
[No Abstract] [Full Text] [Related]
31. Classification of meningiomas-advances and controversies.
Harter PN; Braun Y; Plate KH
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S2. PubMed ID: 28595423
[TBL] [Abstract][Full Text] [Related]
32. [Malignant meningiomas. Anatomo-clinical considerations of 2 cases].
Granata F; Bracale C; Longhi P; Cacace R; Terracciano LM
Riv Neurobiol; 1983; 29(4):566-76. PubMed ID: 6678477
[No Abstract] [Full Text] [Related]
33. Pathology and molecular genetics of meningioma: recent advances.
Shibuya M
Neurol Med Chir (Tokyo); 2015; 55(1):14-27. PubMed ID: 25744347
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic findings in typical and atypical meningioma.
Meloni A; Morgan R; Bridge J; Erling MA; Lewin RJ; Sandberg AA
Cancer Genet Cytogenet; 1991 Jan; 51(1):35-9. PubMed ID: 1984845
[TBL] [Abstract][Full Text] [Related]
35. [Meningiomas and their cytogenetic implication].
Portero JA; García Quesada L; Rey JA; Ayuso C
Rev Clin Esp; 1980 Jul; 157(5):305-8. PubMed ID: 7403603
[No Abstract] [Full Text] [Related]
36. Radiation-induced meningiomas: clinical, cytogenetic, and microarray features.
Lillehei KO; Donson AM; Kleinschmidt-DeMasters BK
Acta Neuropathol; 2008 Sep; 116(3):289-301. PubMed ID: 18604545
[TBL] [Abstract][Full Text] [Related]
37. Meningiomas: A continuum of progress in risk-stratification.
Chacko G
Neurol India; 2018; 66(1):161-162. PubMed ID: 29322979
[No Abstract] [Full Text] [Related]
38. Genomic landscape of intracranial meningiomas.
Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
[TBL] [Abstract][Full Text] [Related]
39. Molecular and genetic characterization of meningiomas: future predictive assays and "personalized" treatment.
Elder JB; Chiocca EA
World Neurosurg; 2013 Feb; 79(2):247-8. PubMed ID: 22120235
[No Abstract] [Full Text] [Related]
40. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
